Published in Drug Week, June 5th, 2009
"The recombinant NtCP56 showed a high activity towards casein. Kinetic analysis revealed a K-m of 2.20 mg ml(-1) and V-max of 11.07 mu g ml(-1) min(-1). The recombinant NtCP56 retained more than 50% of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.